MAPK8 and asthma: Further work investigating the contribution of other MAPKKK upstream of JNK and p38 MAPK, as well as the involvement of other signaling pathways may help identify other possible drug targets that selectively inhibit ASM migration for the treatment of COPD and other diseases whose pathogenesis results from deficiencies in normal ASM function such as asthma.